BioHealth News Archive

Roche gets jump on rivals in race for progressive MS treatment – ET HealthWorld

Roche gets jump on rivals in race for progressive MS treatment – ET HealthWorld

Switzerland's Roche has moved into pole position in the race to launch the world's first treatment for progressive multiple sclerosis but smaller players are…

Read More
Medtronic Grant For Health Incubator

Medtronic Grant For Health Incubator

Medtronic, the international medical technology and services company, announced that it has received a grant from the Israeli government to launch a digital medicine…

Read More
Accelerator Corporation Completes $62.8 Million Oversubscribed Financing – MarketWatch

Accelerator Corporation Completes $62.8 Million Oversubscribed Financing – MarketWatch

Accelerator Corporation, a leading life science investment and management firm, today announced that it has secured an additional $11.7 million in new investment commitments,…

Read More
Exclusive: Restaurants and retail — and lots of research — all part of Inova’s vision for Exxon Mobil campus (Video) – Washington Business Journal

Exclusive: Restaurants and retail — and lots of research — all part of Inova’s vision for Exxon Mobil campus (Video) – Washington Business Journal

Health-focused restaurants and retailers, as well as technology-centered businesses, will someday be a part of Inova Health System's Center for Personalized Health, officials said…

Read More
Top 10 Pharma Firms of 2015 – GEN

Top 10 Pharma Firms of 2015 – GEN

Big pharma has a big public perception problem among Americans, according to Gallup poll results released September 14. Of more than 1,000 Americans polled,…

Read More
University vs. industry: Boston gathering takes on biotech’s longstanding divide – Boston Business Journal

University vs. industry: Boston gathering takes on biotech’s longstanding divide – Boston Business Journal

It was like any other contest where startup founders pitch their ideas to a skeptical audience, except the majority of the people doing the…

Read More
A Johns Hopkins team designed an Ebola suit so good, it’s going on the market – The Washington Post

A Johns Hopkins team designed an Ebola suit so good, it’s going on the market – The Washington Post

Youseph Yazdi was surprised by the number of people who jumped in to help design better protective gear for people helping Ebola victims –…

Read More
Expanding the Reach of Precision Medicine – Promising Practices – Management – GovExec.com

Expanding the Reach of Precision Medicine – Promising Practices – Management – GovExec.com

Readers of the NIH Director’s Blog know how excited I am about the potential of precision medicine for revolutionizing efforts to treat disease and…

Read More
Pittsburgh Life Sciences Greenhouse Accelerator Fund II closes on $4 million, could raise as much as $12 million – Pittsburgh Business Times

Pittsburgh Life Sciences Greenhouse Accelerator Fund II closes on $4 million, could raise as much as $12 million – Pittsburgh Business Times

The Pittsburgh Life Sciences Greenhouse Accelerator Fund II has closed on $4 million, according to a filing with the U.S. Securities and Exchange Commisison.…

Read More
Sisu Global Heath wins $100,000 investment from AOL co-founder Steve Case – Baltimore Sun

Sisu Global Heath wins $100,000 investment from AOL co-founder Steve Case – Baltimore Sun

A Baltimore startup that developed a surgical tool to recycle the blood of a patient suffering from internal bleeding landed a $100,000 investment Monday…

Read More
Roche Drug First to Clear Clinical Trials for Hard-to-Treat Form of Multiple Sclerosis – Scientific American

Roche Drug First to Clear Clinical Trials for Hard-to-Treat Form of Multiple Sclerosis – Scientific American

Switzerland's Roche has moved into pole position in the race to launch the world's first treatment for progressive multiple sclerosis but smaller players are…

Read More
NIH Wants to License Out a Mobile App to the Private Sector – Nextgov.com

NIH Wants to License Out a Mobile App to the Private Sector – Nextgov.com

The National Institutes for Health is trying to commercialize its inventions by licensing them out, a new Federal Register notice shows.  The technology available…

Read More
The beginning of Precision Medicine marks the beginning of the end of common diseases…

The beginning of Precision Medicine marks the beginning of the end of common diseases…

The use of a patient's or tumor's DNA sequence to diagnose/characterize a disease and select or discover drugs that have the highest likelihood of…

Read More
Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease

Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease

Vtesse, Inc. today announced that the first three patients have been screened for inclusion in its pivotal Phase 2b/3 clinical trial with VTS-270 for…

Read More
‘Megafund’ proposed to spur drug development for rare disease – The Boston Globe

‘Megafund’ proposed to spur drug development for rare disease – The Boston Globe

Three years ago, MIT finance professor Andrew Lo proposed rallying private investors to raise an eye-popping $30 billion to develop cancer drugs. That idea…

Read More